Novartis

Novartis' Cosentyx racks up more long-term data in psoriatic arthritis and ankylosing spondylitis
Fierce Pharma
Thu, 06/15/17 - 05:36 pm
Novartis
Cosentyx
psoriatic arthritis
ankylosing spondylitis
With Novartis and Google jumping in, Medicxi unveils a $300M late-stage biotech fund with a transatlantic scope
Endpoints
Wed, 06/14/17 - 09:45 pm
Novartis
Google
Medicxi
biotech
Verily
Amgen loses its bid to delay biosimilars as SCOTUS hands Novartis a victory
Endpoints
Mon, 06/12/17 - 09:24 pm
Amgen
Novartis
Supreme Court
biosimilars
Neulasta
FDA
Coherus Biosciences
Novartis’s Next Challenge: Pricing Breakthrough Cancer Treatment
Bloomberg
Thu, 06/8/17 - 10:24 pm
Novartis
drug pricing
CTL019
cancer
CAR-T
Novartis' CAR-T stacks up to Kite in lymphoma
BioPharma Dive
Wed, 06/7/17 - 07:04 pm
Novartis
CAR-T
Kite Pharma
CTL019
axi-cel
lymphoma
July 12 FDA panel review looms as a watershed moment in Novartis’ campaign to win an historic new drug OK
Endpoints
Tue, 06/6/17 - 12:13 pm
Novartis
FDA
CAR-T
advisory panels
CTL019
pediatric B-cell acute lymphoblastic leukemia
Novartis, IBM Watson collab to optimize care for patients with advanced breast cancer
Drug Delivery Business News
Mon, 06/5/17 - 12:07 pm
Novartis
IBM Watson
advanced breast cancer
patients
breast cancer
Why Novartis' Shah-Mehta chose a career in pharma sales
Medical Marketing and Media
Sat, 06/3/17 - 09:16 am
Novartis
marketing
oncology
Novartis sees gaps in cancer pipeline but is adamant it doesn’t need an I-O deal
Fierce Biotech
Thu, 06/1/17 - 09:01 am
Novartis
cancer
immuno-oncology
Novartis' Zykadia gets 1st-line nod in ALK+ lung cancer
BioPharma Dive
Thu, 06/1/17 - 09:00 am
Novartis
Zykadia
ALK-positive non-small cell lung cancer
Novartis' Zykadia piles pressure on Pfizer's Xalkori, Roche's Alecensa with new lung cancer nod
Fierce Pharma
Wed, 05/31/17 - 09:32 am
Novartis
Zykadia
Pfizer
Xalkori
Roche
Alecensa
non-small cell lung cancer
Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for
Endpoints
Tue, 05/30/17 - 11:48 am
ASCO
IDO inhibitors
CAR-T
PDL-1 inhibitors
Merck
Incyte
NewLink Genetics
Novartis
Juno Therapeutics
Bristol-Myers Squibb
Potential Alcon sale worries Novartis investors
Drug Delivery Business News
Tue, 05/30/17 - 10:14 am
Novartis
Alcon
devices
M&A
eye health
Prescribed Reading: FDA on a roll, while pharma continues sell off
BioPharma Dive
Tue, 05/30/17 - 10:07 am
FDA
Roche
Ocrevus
Puma Biotechnology
neratinib
Novartis
EMA recommends 11 drugs for approval in May meeting
BioPharma Dive
Thu, 05/25/17 - 09:26 am
EMA
Europe
Sanofi
AstraZeneca
LEO Pharma
Novartis
Pfizer
Novartis to sever 250 U.S. workers days after announcing 500 cuts in Switzerland
Fierce Pharma
Wed, 05/24/17 - 10:54 am
Novartis
layoffs
Pfizer bows first Ibrance TV spot as Novartis revs up with rival breast cancer med Kisqali
Fierce Pharma
Wed, 05/24/17 - 10:37 am
Pfizer
Ibrance
Novartis
breast cancer
drug ads
Novartis is sending 500 jobs to the scrap heap while adding 350 ‘high-tech’ positions for growth
Endpoints
Thu, 05/18/17 - 07:56 pm
Novartis
layoffs
R&D
Blockbuster cancer drug shows surprising promise in treating severe asthma
Stat
Thu, 05/18/17 - 12:07 am
Gleevec
severe asthma
asthma
Novartis
The top 15 generic drugmakers by 2016 revenue
Fierce Pharma
Wed, 05/17/17 - 09:39 am
generics
Teva Pharmaceutical
Mylan Labs
Novartis
Pfizer
Allergan

Pages